Acute heart failure: A novel approach to its pathogenesis and treatment

European Journal of Heart Failure

Volumn 4, Issue 3, 2002, Pages 227-234

  Cotter, Gad ^a   Moshkovitz, Yaron ^a   Milovanov, Olga ^a   Salah, Ahmed ^a   Blatt, Alex ^a   Krakover, Ricardo ^a   Vered, Zvi ^a   Kaluski, Edo ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; N(G) METHYLARGININE; NITRATE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE INHIBITOR; VASODILATOR AGENT;

ACUTE HEART FAILURE; CARDIOGENIC SHOCK; DISEASE CLASSIFICATION; HEART AFTERLOAD; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEMODYNAMICS; HYPERTENSION; HYPOTENSION; LUNG CAPILLARY; LUNG EDEMA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASCULAR RESISTANCE;

ACUTE DISEASE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; PULMONARY EDEMA; SHOCK, CARDIOGENIC; SYNDROME; VASCULAR RESISTANCE;

EID: 0036623850     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(02)00017-X     Document Type: Review

References (17)

1. Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998;351:389-93.
2. Hochman JS, Sleeper LA, Sanbom TA, et al. Early revasularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999;341:625-34.
3. Cotter G, Kaluski E, Blatt A, et al. L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock. Circulation 2000;101:1358-61.
4. Gandhi SK, Powers JC, Nomier AM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. New Engl. J. Med. 2001;344:17-22.
5. Cotter G, Moshkovitz Y, Kaluski E et al. The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure (submitted).
6. Sharon A, Shpirer I, Kaluski E, et al. High-dose intravenous isosorbide-dinitrate is safer and better than BI-PAP ventilation combined with conventional treatment for severe pulmonary edema. J. Am. Coll. Cardiol. Sep. 2000;36:832-7.
7. Atherton JJ, Moore TD, Lele SS, et al. Diastolic ventricular interaction in chronic heart failure. Lancet 1997;349:1720-4.
8. Sacetti A, Ramoska E, Moakes ME, McDermott P, Moyer V. Effect of ED management on ICU use in acute pulmonary edema. Am J Emerg Med 1999;6:571-4.
9. Masip J, Betbesé AJ, Páez J, et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial. Lancet 2000;356:2126-30.
10. Northridge D. Furosemide or nitrates for acute heart failure? The Lancet 1996;347:667-8.
11. Nieminen MS, Akkila J, Hasenfuss G, et al. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Cardiol 2000;15:1903-12.
12. Slawsky MT, Colucci WS, Gottlieb SS, et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 2000;102:2222-30.
13. Torre-Amione G, Young JB, Colucci WS, Lewis BS, Pratt C, Cotter G, Stangl K, Elkayam U, Frey A, Rainisio M, Kobrin I. Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure, submitted.
14. Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000;343(4):246-53.
15. Dikshit K, Vyden JK, Forrester JS, Chatterjee K, Parkash R, Swan HJC. Renal and extrarenal haemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 1973;288:1087-90.
16. Nelson GIC, Silke B, Ahuja RC, Hussain M. Hemodynamic advantages of isosorbide dinitrate over furosamide in acute heart failure following myocardial infarction. Lancet 1983;1:730-2.
17. Cotter G, Weissgarten J, Metzkor E, et al. Increased toxicity of high-dose furosamide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther 1997;62:187-93.